“…In a study of 380 adult Iranian women, the lower levels of HDL were observed in the risk genotypes compared to the non-risk genotype of FTO ( 23 ). The mechanism of FTO polymorphism affecting lipid metabolism has not been fully understood, but it has been reported that FTO could interact with calmodulin-dependent protein kinase II (CaMKII), thereby prolonging CREB phosphorylation and affecting the expression levels of Brain-derived neurotrophic factor (BDNF) and NPY1R neuropeptide Y receptor Y1 (NPY1R), which were related to lipid metabolic process ( 24 ). Besides, FTO catalyzes the demethylation of m6A to alter the processing, maturation, and translation of the mRNAs of lipid-related genes ( 25 ).…”